UB Paderborn / Katalog / Suche / in CDI

The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics

The Journal of pharmacology and experimental therapeutics, 2003-05, Vol.305 (2), p.410

2003

Volltextzugriff (PDF)

Fundamental molecular mechanism of the CNS effects of TRH

Trends in pharmacological sciences (Regular ed.), 2003-12, Vol.24 (12), p.617-618

Yarbrough, George G

2003

Volltextzugriff (PDF)

SCREENING MICROBIAL METABOLITES FOR NEW DRUGS - THEORETICAL AND PRACTICAL ISSUES

The Journal of Antibiotics, 1993/04/25, Vol.46(4), pp.535-544

1993

Volltextzugriff (PDF)

Aminomethyl-1,2,4-benzothiadiazines as potential analogs of .gamma.-aminobutyric acid. Unexpected discovery of a taurine antagonist

Journal of medicinal chemistry, 1982-02, Vol.25 (2), p.113-116

1982

Volltextzugriff (PDF)

On the neuropharmacology of thyrotropin releasing hormone (TRH)

Progress in neurobiology, 1979, Vol.12 (3-4), p.291-312

Yarbrough, G G

1979

Volltextzugriff (PDF)

Thyrotropin releasing hormone and CNS cholinergic neurons

Life Sciences, 1983-01, Vol.33 (2), p.111-118

Yarbrough, George G.

1983

Volltextzugriff (PDF)

Molecular Approaches to Receptors as Targets for Drug Discovery

Journal of receptors and signal transduction, 1997-01, Vol.17 (5), p.671-776

1997

Volltextzugriff (PDF)

In vivo bahavioral assessment of central nervous system purinergic receptors

European journal of pharmacology, 1981-12, Vol.76 (2), p.137-144

1981

Volltextzugriff (PDF)

Supersensitivity of caudate neurones after repeated administration of haloperidol

European journal of pharmacology, 1975-04, Vol.31 (2), p.367-369

Yarbrough, George G.

1975

Volltextzugriff (PDF)

The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD)

Progress in neuro-psychopharmacology & biological psychiatry, 1985, Vol.9 (3), p.285-289

1985

Volltextzugriff (PDF)

Enhancement of in vitro binding and some of the pharmacological properties of diazepam by a novel anthelmintic agent, avermectin B 1a

European journal of pharmacology, 1979, Vol.56 (3), p.273-276

1979

Volltextzugriff (PDF)

Prospective strategies for cholinergic interventions in Alzheimer's disease

Progress in neuro-psychopharmacology & biological psychiatry, 1986, Vol.10 (3), p.553-569

1986

Volltextzugriff (PDF)

Electrophysiological, biochemical and behavioral assessment of dopamine autoreceptor activation by a series of dopamine agonists

European journal of pharmacology, 1984-01, Vol.99 (1), p.73-78

1984

Volltextzugriff (PDF)

MK-771-induced electromyographic (EMG) activity in the rat: Comparison with thyrotropin releasing hormone (TRH) and antagonism by neurotensin

European journal of pharmacology, 1979-11, Vol.60 (1), p.41-46

1979

Volltextzugriff (PDF)

MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol — Implications for tardive dyskinesia

Neuroscience letters, 1982-12, Vol.34 (3), p.321-323

1982

Volltextzugriff (PDF)

Cell receptors as drugs. Ligand binding domains of receptors as drugs: a potential new class of therapeutic agents

Journal of the Royal College of Physicians of London, 1991-10, Vol.25 (4), p.309

1991

Volltextzugriff (PDF)

Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database

Head & neck, 2018-07, Vol.40 (7), p.1343-1355

2018

Volltextzugriff (PDF)

Green Fluorescent Protein Variants as Ratiometric Dual Emission pH Sensors. 1. Structural Characterization and Preliminary Application

Biochemistry (Easton), 2002-12, Vol.41 (52), p.15477-15488

2002

Volltextzugriff (PDF)

Structure of a multifunctional protein. Mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine

The Journal of biological chemistry, 2001-03, Vol.276 (12), p.9246-9252

2001

Volltextzugriff (PDF)

Endoscopic management of retained airgun projectiles in the paranasal sinuses

Otolaryngology-head and neck surgery, 2004, Vol.130 (1), p.25-30

2004

Volltextzugriff (PDF)

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

Annals of allergy, asthma, & immunology, 2002-06, Vol.88 (6), p.592-600

2002

Volltextzugriff (PDF)

Modifications of Cysteine Residues in the Solution and Membrane-Associated Conformations of Phosphatidylinositol Transfer Protein Have Differential Effects on Lipid Transfer Activity

Biochemistry (Easton), 2001-08, Vol.40 (31), p.9151-9158

2001

Volltextzugriff (PDF)

Both isoforms of mammalian phosphatidylinositol transfer protein are capable of binding and transporting sphingomyelin

Biochimica et biophysica acta, 2002-01, Vol.1580 (1), p.67-76

2002

Volltextzugriff (PDF)

Limited Proteolysis of Rat Phosphatidylinositol Transfer Protein by Trypsin Cleaves the C Terminus, Enhances Binding to Lipid Vesicles, and Reduces Phospholipid Transfer Activity

The Journal of biological chemistry, 1996-08, Vol.271 (35), p.21075-21080

1996

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics

Fundamental molecular mechanism of the CNS effects of TRH

SCREENING MICROBIAL METABOLITES FOR NEW DRUGS - THEORETICAL AND PRACTICAL ISSUES

Aminomethyl-1,2,4-benzothiadiazines as potential analogs of .gamma.-aminobutyric acid. Unexpected discovery of a taurine antagonist

On the neuropharmacology of thyrotropin releasing hormone (TRH)

Thyrotropin releasing hormone and CNS cholinergic neurons

Molecular Approaches to Receptors as Targets for Drug Discovery

In vivo bahavioral assessment of central nervous system purinergic receptors

Supersensitivity of caudate neurones after repeated administration of haloperidol

The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD)

Enhancement of in vitro binding and some of the pharmacological properties of diazepam by a novel anthelmintic agent, avermectin B 1a

Prospective strategies for cholinergic interventions in Alzheimer's disease

Electrophysiological, biochemical and behavioral assessment of dopamine autoreceptor activation by a series of dopamine agonists

MK-771-induced electromyographic (EMG) activity in the rat: Comparison with thyrotropin releasing hormone (TRH) and antagonism by neurotensin

MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol — Implications for tardive dyskinesia

Cell receptors as drugs. Ligand binding domains of receptors as drugs: a potential new class of therapeutic agents

Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database

Green Fluorescent Protein Variants as Ratiometric Dual Emission pH Sensors. 1. Structural Characterization and Preliminary Application

Structure of a multifunctional protein. Mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine

Endoscopic management of retained airgun projectiles in the paranasal sinuses

Multicenter Study of Noninvasive Monitoring Systems as Alternatives to Invasive Monitoring of Acutely III Emergency Patients

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

Modifications of Cysteine Residues in the Solution and Membrane-Associated Conformations of Phosphatidylinositol Transfer Protein Have Differential Effects on Lipid Transfer Activity

Both isoforms of mammalian phosphatidylinositol transfer protein are capable of binding and transporting sphingomyelin

Limited Proteolysis of Rat Phosphatidylinositol Transfer Protein by Trypsin Cleaves the C Terminus, Enhances Binding to Lipid Vesicles, and Reduces Phospholipid Transfer Activity

Aktive Filter

Suchergebnisse filtern